Apnea of prematurity is a breathing pause that affects babies born too early. It involves brief stops in breathing and sometimes a slow heart rate and low oxygen. Symptoms usually appear in the first days after birth and improve as the baby’s brain and lungs mature over weeks. Most babies with apnea of prematurity do well with monitoring, gentle stimulation, and treatments like caffeine and breathing support. The outlook is usually good, and death from apnea of prematurity is uncommon in modern neonatal care.
Overview
Apnea of prematuritySymptoms
In apnea of prematurity, early symptoms include brief pauses in breathing, often during sleep. Babies may turn pale or blue, have slow heart rate, low oxygen levels, limpness, or trouble feeding.
Outlook and prognosis
Most babies with apnea of prematurity outgrow the pauses in breathing as their brain and lungs mature, usually by 36–40 weeks postmenstrual age. Care teams monitor closely and may use caffeine therapy or gentle breathing support. Long-term breathing or developmental problems are uncommon.
Causes and risk factors
Apnea of prematurity mostly reflects immature breathing control in the brain. Risk is higher with earlier gestational age and very low birth weight, and may be worsened by anemia, infection, temperature instability, sedating medicines, or rarely neurologic or genetic disorders.
Genetic influences
Genetics plays a modest role in apnea of prematurity. Most cases stem from immature brain and lung control due to early birth, not inherited mutations. Family patterns are uncommon, though genetic variations may slightly influence breathing control and caffeine response.
Diagnosis
Apnea of prematurity is diagnosed by breathing pauses—often 20 seconds or more—with low heart rate or oxygen on NICU monitoring. Teams also rule out other causes, such as infection or anemia; this is the diagnosis of Apnea of prematurity.
Treatment and drugs
Care for apnea of prematurity focuses on supporting breathing while the brain’s breathing control matures. Teams often use gentle stimulation, safe positioning, caffeine therapy, and, if needed, nasal support like CPAP. Monitoring guides when to lessen support and prepare for discharge.
Symptoms
In the NICU, you may notice a preterm baby pause their breathing, look pale, or seem limp for a moment. These brief spells are typical of apnea of prematurity and tend to appear in the first weeks after birth. Symptoms vary from person to person and can change over time. Early symptoms of apnea of prematurity can be easy to miss, which is why monitors and the care team keep close watch.
Breathing may stop for 20 seconds or more, or for a shorter time with color change or a slow pulse. With apnea of prematurity, these pauses often happen during sleep or after a feeding. Gentle touch or repositioning usually restarts steady breathing.
The skin may look pale or bluish, especially around the lips or face. Color returns once breathing and oxygen improve. Staff may add oxygen or airflow if it doesn’t quickly resolve.
The heart rate drops below what’s expected for a newborn during a spell. Clinicians call this bradycardia, which means the heart is beating more slowly than usual. It often occurs alongside a breathing pause.
The oxygen number on the monitor dips during an episode. This can trigger color changes or sleepiness. Levels usually improve with gentle stimulation or brief respiratory support.
How people usually first notice Apnea of prematurity?
Apnea of prematurity is usually first noticed in the neonatal intensive care unit when a premature baby has pauses in breathing longer than about 20 seconds or shorter pauses accompanied by color change (pale or blue), limpness, or a slow heart rate. Nurses and doctors often detect these events on cardiorespiratory monitors, but parents may first see the baby stop breathing, look dusky, or need gentle stimulation to restart regular breaths. These first signs of apnea of prematurity typically appear within the first days after birth in babies born before about 34 weeks, and the care team will evaluate other causes (like infection, low temperature, low sugar, or reflux) while starting supportive treatments.
Types of Apnea of prematurity
Apnea of prematurity has a few well-recognized types that reflect how the breathing pause starts in a preterm newborn. Understanding the types of apnea of prematurity can make it easier to notice patterns, like whether a pause begins with no effort to breathe, with an airway blockage, or a mix of both. People may notice different sets of symptoms depending on their situation. Not everyone will experience every type.
Central apnea
Breathing effort briefly stops because the brain’s breathing control is immature. Babies may look still and quiet with no chest movement during the pause. Color can fade and the heart rate may dip until the baby is stimulated or the pause ends.
Obstructive apnea
The baby tries to breathe, but airflow is blocked, often from the relaxed airway collapsing. You might see chest and belly movement without air moving in and out. Gentle repositioning or airway support often helps restore airflow.
Mixed apnea
A pause starts centrally and then picks up an airway blockage, or the reverse. For many, certain types stand out more than others. This is the most common pattern in preterm infants and can vary in length and severity from episode to episode.
What genetics can tell you about symptoms
Certain gene differences in breathing control pathways, like those guiding serotonin and adenosine signaling, can make preterm babies pause breathing longer and more often. These variations are linked to symptoms such as repeated apnea spells, low oxygen levels, and color changes.
Causes and risk factors
The main cause is immature breathing control in babies born early. In apnea of prematurity, the brain's breathing center and the airway muscles are not fully developed yet. Risk factors for apnea of prematurity include earlier gestational age, very low birth weight, infection, anemia, low body temperature, and low blood sugar. Parental factors like smoking in pregnancy can add risk, while genetics are not a common cause. Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
When a baby is born early, breathing control is still maturing, so certain conditions can make pauses in breathing more likely. Apnea of prematurity often comes and goes in the neonatal unit, and episodes may cluster on stressful days. Doctors often group risks into internal (biological) and external (environmental). These risks don’t change the early symptoms of apnea of prematurity, but they can make episodes more frequent or longer.
Babies born before about 28–30 weeks have very immature breathing control. Earlier gestational age increases the chance and number of apnea episodes. Risk usually drops as the brain matures.
Birth weight under 1,500 g (about 3 lb 5 oz) is linked with more apnea. Smaller infants have less reserve to keep a steady breathing rhythm. This raises the chance of apnea of prematurity.
The brain’s breathing center is still developing in preterm babies. It may briefly “forget” to trigger breaths during sleep, causing pauses. Maturation over weeks reduces this problem.
Respiratory distress or ongoing lung disease increases breathing effort and instability. These stresses can trigger pauses in breathing. This can worsen apnea of prematurity while the lungs recover.
Genetic risk factors
Genes can play a role in how vulnerable a preterm baby is to apnea of prematurity and how quickly that risk fades as the brain matures. Some influences act indirectly by increasing the chance of being born early, while others affect the brain’s breathing control circuits themselves. Risk is not destiny—it varies widely between individuals. Clinicians and families sometimes ask about genetic risk factors for apnea of prematurity to help guide testing and follow-up.
Genetic prematurity risk: Genes passed from the mother and baby can influence the timing of birth. Because apnea of prematurity happens in babies born early, inherited tendencies toward preterm delivery can indirectly raise apnea risk.
Male sex: Preterm boys have a slightly higher chance of apnea episodes than girls. This likely reflects sex-linked differences in brain and lung maturation that are rooted in biology, not anything parents did.
PHOX2B disorders: A rare condition called congenital central hypoventilation syndrome, caused by changes in the PHOX2B gene, can present with severe central apnea. Having a family history of this syndrome (or related issues like Hirschsprung disease) raises the chance in a newborn.
Breathing control genes: Rare genetic changes that affect the brainstem’s drive to breathe and how we sense carbon dioxide or oxygen can increase susceptibility to apnea in preterm babies. These single-gene causes are uncommon but are important to consider when apnea is unusually severe or atypical.
Lifestyle risk factors
Apnea of prematurity is not caused by caregiver habits, but daily care choices can influence how often events happen and how severe they are. Understanding how lifestyle affects Apnea of prematurity helps families create steadier routines and environments. Below are practical lifestyle risk factors for Apnea of prematurity to help guide home care after discharge.
Secondhand smoke can irritate the airways and destabilize breathing, increasing apnea and desaturation events. Keep the home and car completely smoke-free and avoid vaping aerosols around the infant.
Fast, large, or poorly paced feeds can trigger reflux that can precipitate apnea or bradycardia. Use paced feeding with frequent pauses and keep the baby upright for 20–30 minutes after feeds.
Neck flexion or slumped positions can partially block the airway and worsen apnea. Place the baby supine on a flat, firm surface and avoid devices that let the chin fall to the chest.
Extended time in car seats, swings, or slings can promote airway narrowing in preterm infants. Limit time in these devices and ensure proper head and neck alignment when use is necessary.
Risk prevention
Apnea of prematurity happens because a preterm baby’s breathing control is still maturing, so prevention focuses on lowering the chance of preterm birth and reducing breathing pauses in the NICU. Some prevention is universal, others are tailored to people with specific risks. In practice, this means good prenatal care before birth and careful, supportive care after birth. The steps below aim to reduce events and protect the brain and lungs while a baby grows stronger.
Regular prenatal care, managing chronic conditions, and treating infections lower the chance of early delivery. Avoiding smoking, alcohol, and illicit drugs also reduces the risk of apnea of prematurity by lowering the risk of prematurity.
If preterm birth is likely, steroid shots during pregnancy help the baby’s lungs mature. Better lung function can reduce breathing pauses linked to apnea of prematurity.
Caffeine medicine helps stabilize breathing in preterm infants. It lowers how often and how long apnea of prematurity episodes occur.
Soft, steady air flow (like CPAP) can help keep the airways open. This support reduces pauses from apnea of prematurity while the brain and lungs develop.
Transmission
Apnea of prematurity is not contagious. It cannot be transferred from one baby to another, and it isn’t an inherited disorder; it happens because babies born very early have immature breathing control. There is no spread through the air, touch, breast milk, or shared equipment, though standard NICU hygiene remains important to prevent unrelated infections. People often ask how apnea of prematurity is transmitted or how contagious apnea of prematurity is; it doesn’t spread and typically improves as the nervous system matures.
When to test your genes
Test if your baby is very premature, has repeated apnea spells without a clear cause, or there’s a family history of inherited breathing control disorders. Genetic testing can clarify risks, guide monitoring, and tailor caffeine or ventilation strategies. Discuss timing with your neonatology team, since some results change management now, while others inform long‑term care.
Diagnosis
In the NICU, apnea of prematurity is usually picked up when nurses and monitors show repeated pauses in breathing, drops in oxygen, or a slow heart rate in a preterm baby. Getting a diagnosis is often a turning point toward answers and support. Doctors focus on confirming the pattern and making sure nothing else—like infection, low blood sugar, or anemia—is causing the events. The diagnosis of apnea of prematurity is clinical, supported by monitor data and tests that rule out other problems.
Babies wear heart and oxygen monitors that record pauses in breathing and changes in heart rate. Staff review patterns and alarms to confirm true events rather than brief, harmless dips.
Nurses note what happened, how long it lasted, and how the baby responded to gentle stimulation or positioning. This helps distinguish typical apnea episodes from equipment artifacts.
Doctors consider how early the baby was born because apnea is more common in those born very preterm. Knowing the maturity level helps guide how strongly apnea of prematurity is suspected.
A quick glucose check looks for low blood sugar, which can trigger breathing pauses. Correcting low glucose can reduce apnea-like episodes.
Stages of Apnea of prematurity
Apnea of prematurity does not have defined progression stages. Episodes tend to come and go and usually lessen as a baby’s breathing control matures rather than moving through set phases. Different tests may be suggested to help rule out other causes of pauses in breathing and to guide care. In the NICU, apnea of prematurity is diagnosed and monitored with continuous heart and oxygen checks, noting pauses in breathing (often around 20 seconds, or shorter if there’s color change, a slow heart rate, or low oxygen), plus bedside exams and, when needed, simple blood tests; early symptoms of apnea of prematurity can include brief breathing pauses, color change, or becoming floppy during feeds or sleep.
Outlook and prognosis
Many families wonder how long apnea of prematurity will last and what it means for day-to-day life in the nursery. For most preterm infants, breathing pauses steadily improve as the brain’s breathing control matures; many babies outgrow events by 36–40 weeks post‑menstrual age, though very early or very small infants may need more time. Early care can make a real difference, and treatments like gentle breathing support, caffeine, and careful monitoring help reduce events and keep oxygen levels steady.
Prognosis refers to how a condition tends to change or stabilize over time. In apnea of prematurity, the long-term outlook is usually good once the infant reaches the developmental stage when brain–lung coordination catches up. Most babies who needed brief medication or monitoring do not have lasting breathing problems, and typical feeding, growth, and sleep patterns resume. Severe cases linked with very early birth or other illnesses can take longer to resolve, and a small number of infants may go home with monitors for a short period as a precaution.
Looking at the long-term picture can be helpful. The risk of death from apnea of prematurity itself is low in modern neonatal units, but overall mortality is shaped by how premature the infant is and by other medical issues common in preterm birth. Parents sometimes worry that early symptoms of apnea of prematurity predict lifelong breathing disorders; for most children, they don’t. Talk with your doctor about what your personal outlook might look like, including when medications can be tapered, whether a home monitor is needed, and what signs should prompt a call or visit.
Long-term effects
Apnea of prematurity often improves as a baby’s nervous system matures, and for most, there are no lasting breathing problems. While early symptoms of apnea of prematurity include pauses in breathing and color changes, the long-term picture for most babies is reassuring. Long-term effects vary widely, largely reflecting how early the baby was born and whether other complications were present. Pediatric teams usually follow former preemies through childhood checkups to watch breathing, growth, and development.
For most babies, apnea of prematurity fades by their due date or a few weeks after. Lasting breathing pauses from apnea of prematurity are uncommon.
Apnea of prematurity and sudden infant death syndrome are different conditions. Having apnea spells in the NICU has not been shown to increase a baby's risk of SIDS later.
Babies born very early have a higher chance of hospital visits in the first year for colds, wheezing, or breathing trouble. This risk relates more to prematurity and lung immaturity than to apnea of prematurity itself.
Some children born extremely early may have delays in movement, language, or learning. When apnea of prematurity is frequent and severe, it can travel alongside other risks tied to very premature birth.
How is it to live with Apnea of prematurity?
Life with apnea of prematurity often means living on a monitor’s rhythm—watching for pauses in breathing, heart rate dips, and color changes, especially during sleep or feeds. In the NICU, nurses and parents quickly learn gentle, timed stimulation and positioning to help a baby restart steady breathing, and many go home with a plan for safe sleep, feeding pacing, and sometimes a brief period of home monitoring. For families, it can be tiring and anxiety‑provoking at first, but most babies outgrow these events as their nervous system matures over the first weeks to months, and daily life gradually shifts from vigilance to confidence. Loved ones can help by sharing night duties, keeping routines calm and consistent, and celebrating each small gain in stamina and feedings.
Treatment and drugs
Apnea of prematurity is treated by supporting a baby’s breathing while the brain and lungs mature. Care most often starts with gentle breathing support such as nasal CPAP or high‑flow oxygen, keeping the airway open and oxygen levels stable, and caffeine citrate, a medicine that stimulates breathing and reduces pauses. Nurses and doctors also use simple measures like positioning, keeping the baby warm, and giving small, timed feedings; if a pause happens, a brief gentle touch or repositioning often restarts breathing. If apnea is frequent or severe despite these steps, babies may need temporary assisted breathing with a mask or, rarely, a breathing tube and ventilator, and monitoring in the neonatal intensive care unit continues until events stop for several days. Finding the right therapy can take some time, and your doctor can help weigh the pros and cons of each option.
Non-drug treatment
Apnea of prematurity is managed with hands-on care and equipment that support steady breathing while babies mature. Alongside medicines, non-drug therapies can steady breathing, protect oxygen levels, and help prevent future episodes. Because early symptoms of apnea of prematurity can be subtle, NICU teams rely on careful monitoring and gentle, practical steps. These approaches are tailored to each baby’s size, gestational age, and overall health.
Light rubbing or a brief foot tap can restart breathing during an event. Staff watch closely and use the least stimulation needed. This is often the first step before using devices.
Keeping the head and neck in a neutral position helps keep the airway open. In the NICU, supervised side-lying or prone positioning may reduce pauses in breathing. Back-sleeping is resumed for home once events resolve.
Soft nasal prongs deliver air pressure to keep the airway open and lungs partially inflated. This reduces episodes of apnea of prematurity and helps maintain oxygen levels. Settings are adjusted as the baby grows.
Low-flow oxygen through small nasal tubing can stabilize oxygen levels. It may lessen the frequency and depth of events in apnea of prematurity. Teams regularly check oxygen targets to avoid too much or too little.
Your genes may have an impact on how drugs work for you
Medicines for apnea of prematurity can work differently based on a baby’s genes—especially those affecting how the liver processes caffeine and how the brain’s adenosine receptors respond. These differences may shift the needed dose and the chances of side effects.
Pharmacological treatments
Most babies with apnea of prematurity who need medicine are treated with breathing stimulants. First-line medications are those doctors usually try first, based on safety and evidence. Caffeine is preferred because it works well and tends to have fewer side effects than similar drugs. Other medicines may be considered if apnea events continue despite caffeine or if IV therapy is needed.
This is the first-choice medicine to reduce apnea events and help babies stay off the ventilator. Caffeine dosing for apnea of prematurity is tailored by weight and usually does not require routine blood-level checks. Possible side effects include a faster heart rate and restlessness.
This is an alternative when caffeine is not available or not tolerated. It can help reduce apnea but has a narrower safety range and more side effects. Blood tests are often needed to keep levels in a safe range.
This IV form related to theophylline may be used when IV access is needed or during a transition from ventilator support. It requires close monitoring of drug levels due to a narrow safety margin. Side effects may include feeding intolerance, jitteriness, or changes in heart rate.
This rescue option may be considered when apnea persists despite methylxanthines and respiratory support. Evidence is more limited, and it can cause high blood pressure, irritability, or feeding issues. Use is typically short-term and in specialized settings.
Genetic influences
Parents often ask whether apnea of prematurity is hereditary. Genetics is only one piece of the puzzle, but it may influence how a preterm baby’s brain controls breathing and waking. Most cases of apnea of prematurity happen because these control systems are still immature from being born early, not because of a single inherited disorder. Research suggests that common gene differences can affect how sensitive a baby is to rising carbon dioxide, how easily they arouse from sleep, and how well treatments like caffeine work—so some babies may have more or fewer breathing pauses than others born at the same gestational age. There’s no routine genetic test for apnea of prematurity, and any genetic influence tends to shift risk rather than predict exactly who will have symptoms. If episodes are unusually severe, last well beyond the due-date–corrected age, or come with other concerning signs, doctors may look for rare genetic conditions such as congenital central hypoventilation syndrome to rule out other causes. Overall, family history can add context—especially a history of prematurity—but care plans center on close monitoring and time, which let the nervous system mature.
Is Apnea of prematurity genetic?
Genetics plays a modest role in apnea of prematurity. Most cases stem from immature brain and lung control due to early birth, not inherited mutations. Family patterns are uncommon, though genetic variations may slightly influence breathing control and caffeine response.
Pharmacogenetics—how genetics influence drug effects
Caffeine is the main medicine used to reduce breathing pauses in apnea of prematurity, and babies can respond differently to it. Genes may play a role in two ways: by affecting how sensitive the brain is to caffeine’s action on adenosine receptors, and by influencing how quickly a baby’s liver clears the drug. In very preterm babies, though, the liver pathways that handle caffeine are still maturing, so gestational age, overall health, and other medicines often have a bigger impact than inherited differences. Not every difference in response is genetic, but doctors closely watch breathing patterns and heart rate and adjust the dose based on weight, age, and how the baby is doing.
Early research suggests that genetic differences in these receptors and liver enzymes could help explain why some infants need higher or lower caffeine doses, or why the medicine lasts longer in some than others. Pharmacogenetic testing is not part of routine care for apnea of prematurity, and most babies are treated safely without it. If a baby has unexpected side effects or an unusually weak response, the care team may check caffeine levels and look for other causes first, with genetics considered only if needed.
Interactions with other conditions
In preterm babies, apnea of prematurity often shows up alongside other newborn issues seen in the NICU, which can make day-to-day care more complex. Doctors call it a “comorbidity” when two conditions occur together. Lung problems related to being born early, such as ongoing oxygen needs or chronic lung disease, can make the breathing pauses more frequent or harder to recover from, and infections or fever can trigger extra spells. Low blood counts (anemia), low body temperature, and low blood sugar may also “exacerbate” (make worse) apnea events until those problems are treated. A heart vessel that stays open after birth (a patent ductus arteriosus) and reflux symptoms may occur at the same time as apnea of prematurity, though reflux does not always cause the pauses. Because early symptoms of apnea of prematurity—color changes, limpness, or slower heart rate—can look similar to signs of infection or other illnesses, care teams usually check for these links before adjusting treatment. Repeated oxygen dips from apnea can interact with other prematurity concerns, including the eyes and brain, so teams coordinate monitoring and therapies to keep oxygen levels within a safe range.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and nurses in neonatal units long noticed that some very small newborns would pause their breathing, then stir and start again after a gentle tap or a burst of air. Notes in early nursery logs described these spells happening more often in babies born much earlier than expected, especially during sleep, and easing as the weeks went by.
From early theories to modern research, the story of apnea of prematurity moved from bedside observation to careful measurement. Early reports in the mid-20th century linked repeated breathing pauses with drops in heart rate and skin color changes. Clinicians tried simple measures first—position changes, keeping babies warm, and light stimulation—and saw that many episodes stopped with these steps. As incubators, oxygen delivery, and continuous heart–breathing monitors became standard, patterns became clearer: the earlier the gestational age, the more frequent the events, and the more likely they were to cluster during certain sleep phases.
Initially understood only through symptoms, later studies in the 1970s and 1980s mapped how the immature brain’s breathing control and the airway’s tendency to close both contribute. This helped distinguish pauses due to a “forgetful” breathing center from those due to airway collapse, even though many babies have a mix. Researchers also recognized that anemia, infection, or temperature swings could make spells worse, guiding teams to look for and treat these triggers.
With each decade, care evolved alongside technology. Continuous positive airway pressure (CPAP) and gentle ventilation supported babies who needed more than stimulation. Caffeine therapy emerged as a safer, longer-acting option than older medicines, reducing events and shortening time on breathing support. As survival improved for very preterm infants, apnea of prematurity was no longer seen as rare but as a common, usually temporary challenge of early birth.
Understanding broadened beyond the nursery. Follow-up clinics tracked when episodes stop—often by 34 to 36 weeks postmenstrual age—and confirmed that most babies outgrow apnea of prematurity without long-term breathing problems. At the same time, caregivers learned to watch for related features at home, such as brief color changes or pauses on monitors sent with families for a short time after discharge, balancing safety with avoiding unnecessary alarms.
In recent decades, awareness has grown that definitions and monitoring thresholds can differ between hospitals and countries, which shapes how often apnea is recorded and treated. Despite evolving definitions, the core insight remains steady: these breathing pauses reflect immaturity, tend to lessen with time, and respond to supportive care. Today’s approach—careful monitoring, gentle support, and targeted medicines when needed—rests on decades of observation and study, offering reassurance to families while keeping babies safe during those early weeks.